细胞银行外包市场规模、份额和成长分析（按类型、产品、细胞类型、阶段和地区）- 产业预测 2025-2032

2023 年全球手机银行外包市场规模价值 133 亿美元，预计将从 2024 年的 155.9 亿美元成长到 2032 年的 554.9 亿美元，预测期内（2025-2032 年）的复合年增长率为 17.2%。

在冷冻保存和细胞库准备技术的进步的推动下，全球细胞库外包市场预计将显着成长。干细胞疗法的普及以及对单株抗体和有效生物製药的需求不断增加，进一步推动了该领域的发展。 2020 年初，全球先进细胞疗法临床试验数量激增 30%，凸显了对细胞银行服务日益增长的需求。政府的支持措施和细胞株保存和表征方面的创新技术为市场扩张提供了动力。 Opsis Therapeutics 和 FUJIFILM Cellular Dynamics 等领先产业公司之间的合作正在推动研发工作，包括证明人类诱导多功能细胞在改善健康结果方面的有效性的研究。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 次要和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析

手机银行外包市场规模（按类型和复合年增长率）（2025-2032）

• 市场概况
• 主细胞库
• 病毒细胞库
• 工作细胞库

手机银行外包市场规模（按产品和复合年增长率） (2025-2032)

• 市场概况
• 脐带细胞储存
• 成人干细胞储存
• 诱导性多功能干细胞储存
• 胚胎干细胞储存

细胞银行外包市场规模（按细胞类型和复合年增长率） (2025-2032)

• 市场概况
• 干细胞
  • 脐带细胞储存
  • 胚胎干细胞储存
  • 成人干细胞储存
  • 牙科干细胞库
  • IPS 干细胞库
• 非干细胞

手机银行外包市场规模（依阶段划分）及复合年增长率（2025-2032）

• 市场概况
• 银行储存
  • 主细胞库存储
  • 工作细胞库储存
  • 细胞保存稳定性测试
• 细胞保存稳定性测试
• 银行准备
  • 主细胞库准备
  • 工作细胞库的准备
• 银行特性与测试
  • 安全测试
  • 病毒细胞库
  • 微生物细胞库
  • 基因表现检测
  • 核子医学检查
  • 基因序列检测

手机银行外包市场规模（按地区）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司详细信息
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Charles River Laboratories（USA）
• Lonza（Switzerland）
• Merck KGaA（Germany）
• SGS Societe Generale de Surveillance SA（Switzerland）
• Cryo-Cell International, Inc.（USA）
• LifeCell（India）
• WuXi AppTec（China）
• Eurofins Scientific（Luxembourg）
• Sartorius（Bio Outsource）（Germany）
• BSL Bioservice（Germany）
• Key Developments
• ViaCord（USA）
• StemCyte, Inc.（USA）
• Cryoviva Biotech Pvt. Ltd.（India）

结论和建议

Global Cell Banking Outsourcing Market size was valued at USD 13.3 billion in 2023 and is poised to grow from USD 15.59 billion in 2024 to USD 55.49 billion by 2032, growing at a CAGR of 17.2% during the forecast period (2025-2032).

The global cell banking outsourcing market is poised for substantial growth, fueled by advancements in cryopreservation and cell bank preparation techniques. The increasing prevalence of stem cell therapies, alongside a rising demand for monoclonal antibodies and effective biopharmaceuticals, is further propelling this sector. A notable 30% surge in global enrollments for advanced cell therapy trials in early 2020 underscores the escalating need for cell banking services. Supportive government initiatives and innovative technologies for cell line storage and characterization add momentum to market expansion. Collaborations among key industry players, such as Opsis Therapeutics and FUJIFILM Cellular Dynamics, bolster research and development efforts, exemplified by studies indicating the efficacy of human-induced pluripotent stem cells in enhancing health outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cell Banking Outsourcing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cell Banking Outsourcing Market Segments Analysis

Global Cell Banking Outsourcing Market is segmented by Type, Product, Cell Type, Phase and region. Based on Type, the market is segmented into Master Cell Banking, Viral Cell Banking and Working Cell Banking. Based on Product, the market is segmented into Cord Cell Banking, Adult Stem Cell Banking, Induced Pluripotent Stem Cell Banking and Embryonic Stem Cell Banking. Based on Cell Type, the market is segmented into Stem Cell and Non-Stem Cell. Based on Phase, the market is segmented into Bank Storage, Cell Storage Stability Testing, Bank Preparation and Bank Characterization and Testing. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cell Banking Outsourcing Market

A key factor propelling the global cell banking outsourcing market is the rising adoption of stem cell therapies, which is a burgeoning area within regenerative medicine known for its potential to address a variety of medical conditions. As the appetite for such therapies intensifies, the requirement for stable, high-quality cell lines becomes more pronounced, thereby boosting the demand for specialized cell banking services. Consequently, biopharmaceutical companies and contract research organizations (CROs) are increasingly turning to outsourcing for effective and economical solutions related to the production and preservation of these essential cell lines, ultimately driving market growth in this sector.

Restraints in the Global Cell Banking Outsourcing Market

A significant constraint on the global cell banking outsourcing market is the elevated cost associated with cell banking services. The cell banking process entails thorough testing and characterization to guarantee the quality and safety of cell lines, necessitating substantial investments in specialized equipment and infrastructure, which contributes to heightened service costs. Additionally, strict regulations enforced by regulatory authorities regarding the production and storage of cell lines further exacerbate expenses. Consequently, the high costs of these services may hinder their adoption, particularly in developing regions where healthcare budgets are constrained, creating a barrier to accessing essential cell banking solutions.

Market Trends of the Global Cell Banking Outsourcing Market

The Global Cell Banking Outsourcing market is currently witnessing a significant trend driven by the rising demand for personalized medicine which necessitates the use of genetically tailored cells for effective treatments. As healthcare evolves towards individualized approaches, cell banking firms are increasingly investing in advanced technologies and innovations to produce and store these specific cell types. This trend not only enhances treatment efficacy by aligning therapies with patients' unique genetic profiles but also propels market growth as more healthcare providers seek outsourcing solutions to streamline operations and improve patient outcomes. Consequently, the intersection of personalized medicine and cell banking is poised to reshape market dynamics.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Cell Banking Outsourcing Market Size by Type & CAGR (2025-2032)

• Market Overview
• Master Cell Banking
• Viral Cell Banking
• Working Cell Banking

Global Cell Banking Outsourcing Market Size by Product & CAGR (2025-2032)

• Market Overview
• Cord Cell Banking
• Adult Stem Cell Banking
• Induced Pluripotent Stem Cell Banking
• Embryonic Stem Cell Banking

Global Cell Banking Outsourcing Market Size by Cell Type & CAGR (2025-2032)

• Market Overview
• Stem Cell
  • Cord Cell Banking
  • Embryonic Stem Cell Banking
  • Adult Stem Cell Banking
  • Dental Stem Cell Banking
  • IPS Stem Cell Banking
• Non-Stem Cell

Global Cell Banking Outsourcing Market Size by Phase & CAGR (2025-2032)

• Market Overview
• Bank Storage
  • Master Cell Bank Storage
  • Working Cell Bank Storage
  • Cell Storage Stability Testing
• Cell Storage Stability Testing
• Bank Preparation
  • Master Cell Bank Preparation
  • Working Cell Bank Preparation
• Bank Characterization and Testing
  • Safety Testing
  • Viral Cell Banks
  • Microbial Cell Banks
  • Gene Expression Testing
  • Karyology Testing
  • Gene Sequencing Testing

Global Cell Banking Outsourcing Market Size & CAGR (2025-2032)

• North America (Type, Product, Cell Type, Phase)
  • US
  • Canada
• Europe (Type, Product, Cell Type, Phase)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Product, Cell Type, Phase)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Product, Cell Type, Phase)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Product, Cell Type, Phase)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Charles River Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SGS Societe Generale de Surveillance SA (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cryo-Cell International, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LifeCell (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WuXi AppTec (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sartorius (Bio Outsource) (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BSL Bioservice (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
• Key Developments
• ViaCord (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• StemCyte, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cryoviva Biotech Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations